Idera Pharmaceuticals Stock Price - IDRA

-0.02 (-1.19%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Idera Pharmaceuticals Inc IDRA NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.03 1.82% 1.68 1.64 1.72 1.64 1.65 20:00:00
Bid Price Ask Price Spread Spread % News
1.55 1.72 0.17 9.88% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
685 182,606 $ 1.69 $ 309,036 209,347 1.36 - 4.19
Last Trade Time Type Quantity Stock Price Currency
17:04:30 99 $ 1.66 USD

Idera Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 48.51M 28.87M $ -59.88M -2.27 - 27.42M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Idera Pharmaceuticals News

Loading Messages....

Latest IDRA Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical IDRA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.571.741.521.65221,5050.117.01%
1 Month1.921.941.461.65171,464-0.24-12.5%
3 Months1.772.241.361.79240,900-0.09-5.08%
6 Months2.243.581.362.12182,053-0.56-25.0%
1 Year2.654.191.362.56243,478-0.97-36.6%
3 Years14.0822.961.3613.46935,970-12.40-88.07%
5 Years37.5241.921.3617.511,050,891-35.84-95.52%

Idera Pharmaceuticals Description

Idera Pharmaceuticals Inc is a clinical-stage biopharmaceutical company involved in the discovery, development, and commercialization of innovative therapeutics for oncology and rare diseases. The company has developed two distinct proprietary drug-discovery technology platforms: Toll-like receptor and third-generation antisense technology. The Toll-like receptor technology helped the company create synthetic oligonucleotide-based drug candidates. The 3GA technology is used to create drug candidates to turn off the RNA messengers associated with genes causing various diseases.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.